Kisspeptin and Menopause Research: KNDy Biology and Trial Limits
Explore kisspeptin menopause research, KNDy-neuron biology, the Imperial postmenopausal trial, NK3R drug distinctions, and the evidence still missing.
Category Hormone Signaling Research
Selank Research: Tuftsin Analog Evidence and Limits
Selank research overview for women 40+: tuftsin-analog structure, GABA-A and BDNF study findings, the small human-trial record, and what remains unproven.
PT-141 Research: Bremelanotide Trials and Evidence Limits
Explore PT-141 and bremelanotide research in women, including melanocortin biology, phase 3 trials, FDA scope, midlife evidence gaps, and key limits.
MHT and Alzheimer’s Research: What the 2026 Study Found
A 2026 Neurology cohort study linked estrogen-only menopausal hormone therapy with lower odds of Alzheimer pathology. Review the findings and limits.
Cagrilintide Research: Amylin, CagriSema, and Evidence Gaps
Explore cagrilintide research, amylin biology, CagriSema trial results, evidence limits, and what women over 40 should know about the research gap.
Retatrutide Research Update: GLP-1 Trends
Subject: Retatrutide Research Update: GLP-1 Trends Retatrutide continues to stand out as one of the most closely watched metabolic research compounds in the current peptide landscape. In recent trend monitoring, retatrutide showed strong year-over-year search growth and continued week-over-week momentum,…
CJC-1295: Complete Guide for Canadian Researchers
Complete guide for Canadian researchers on CJC-1295 peptides, covering DAC vs no-DAC differences, controlled laboratory applications, dosing protocols, storage guidelines, and Canadian regulatory considerations.